1. Home
  2. ENTA vs FRST Comparison

ENTA vs FRST Comparison

Compare ENTA & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

N/A

Current Price

$13.20

Market Cap

378.0M

Sector

Health Care

ML Signal

N/A

Logo Primis Financial Corp.

FRST

Primis Financial Corp.

N/A

Current Price

$15.95

Market Cap

404.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTA
FRST
Founded
1995
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
378.0M
404.3M
IPO Year
2012
2006

Fundamental Metrics

Financial Performance
Metric
ENTA
FRST
Price
$13.20
$15.95
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$20.40
N/A
AVG Volume (30 Days)
204.2K
132.7K
Earning Date
05-11-2026
04-23-2026
Dividend Yield
N/A
2.74%
EPS Growth
29.93
477.27
EPS
N/A
0.68
Revenue
$102,814,000.00
N/A
Revenue This Year
$7.76
N/A
Revenue Next Year
N/A
$9.63
P/E Ratio
N/A
$23.69
Revenue Growth
16.48
N/A
52 Week Low
$7.05
$9.55
52 Week High
$17.15
$16.88

Technical Indicators

Market Signals
Indicator
ENTA
FRST
Relative Strength Index (RSI) 45.89 46.21
Support Level $12.48 $15.21
Resistance Level $13.98 $16.82
Average True Range (ATR) 0.62 0.32
MACD -0.03 -0.02
Stochastic Oscillator 18.47 42.17

Price Performance

Historical Comparison
ENTA
FRST

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. The company has two reportable segments: Primis Bank. This segment specializes in providing financing services to businesses in various industries along with consumer and residential loans to individuals. Primis Mortgage. This segment specializes in originating mortgages in a majority of the U.S. The revenue is from Primis Bank.

Share on Social Networks: